mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0088 |
0.8 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.8 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.8 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.0091 |
0.8 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
0.8 |